Table 1.
Profile of samples subject to RNA sequencing.
| Tumor1 | Tumor2 | Tumor3 | Normal1 | Normal2 | Normal3 | |
|---|---|---|---|---|---|---|
| Maternal strain | MOLF/EiJ | MOLF/EiJ | 129S4 | MOLF/EiJ | MOLF/EiJ | 129S4 |
| Paternal strain | 129S4 | 129S4 | 129S4 | 129S4 | 129S4 | 129S4 |
| Kras | G12D | G12D | G12D | wildtype | G12D* | wildtype |
| Cre-addition | Yes | Yes | Yes | Yes | No | No |
| p53 status | wildtype | wildtype | Inactive (flox/flox) | wildtype | wildtype | wildtype |
| Sequence reads | 165,569,498 | 149,208,283 | 164,380,208 | 171,553,662 | 171,393,687 | 180,671,287 |
| % mapped reads | 87.17 | 84.62 | 86.01 | 80.76 | 84.14 | 81.45 |
*
Mutation is in inactive state until Cre recombinase is expressed